Section(X) | Body System(W) | Operation(0) | Approach(3) | Qualifier(5) | Device / Substance / Technology(U) | Body Part(4) |
New Technology | Anatomical Regions | Introduction | Percutaneous | New Technology Group 5 | COVID-19 Vaccine | Central Vein |
No record found
Change Type | Change Date | Previous Descriptor |
Code Deleted | 09-30-2024 | Introduction of Imipenem-cilastatin-relebactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 |
Code Added | 10-01-2019 |